SCHEMBL14005382

SCHEMBL14005382

CC(C)(C)c1cncc(OC[C@@H](N)CNC(C)(C)c2ccncc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 17/20 0.42
ROCK2 O75116 2/20 0.39
PIM1 P11309 2/20 0.39
PRKACA P17612 2/20 0.39
RPS6KB1 P23443 2/20 0.39
GSK3A P49840 2/20 0.39
GSK3B P49841 2/20 0.39
PRKCD Q05655 2/20 0.39
ROCK1 Q13464 2/20 0.39
DYRK1A Q13627 2/20 0.39
CDC42BPA Q5VT25 2/20 0.39
CHUK O15111 1/20 0.39
AKT2 P31751 1/20 0.39
CSNK1D P48730 1/20 0.39
RPS6KA5 O75582 1/20 0.38
MAP4K4 O95819 1/20 0.38
CLK2 P49760 1/20 0.38
PRKX P51817 1/20 0.38
PRKG2 Q13237 1/20 0.38
PRKG1 Q13976 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14005332 0.91 AKT1 (0.42) AKT1ROCK2PIM1PRKACARPS6KB1
SCHEMBL14005342 0.89 AKT1 (0.44) AKT1ROCK2PIM1PRKACARPS6KB1
SCHEMBL14030222 0.86 AKT1 (0.43) AKT1ROCK2PIM1PRKACARPS6KB1
SCHEMBL14005324 0.85 CYP2D6 (0.37) AKT1ROCK2PIM1PRKACARPS6KB1
SCHEMBL14005343 0.84 AKT1 (0.39) AKT1ROCK2PIM1PRKACARPS6KB1
SCHEMBL14005442 0.84 AKT1 (0.45) AKT1ROCK2PIM1PRKACARPS6KB1
SCHEMBL14005355 0.81 AKT1 (0.43) AKT1ROCK2PIM1PRKACARPS6KB1
SCHEMBL14005318 0.78 AKT1 (0.47) AKT1ROCK2PIM1PRKACARPS6KB1
SCHEMBL14005466 0.78 AKT1 (0.40) AKT1ROCK2PIM1PRKACARPS6KB1
SCHEMBL14005330 0.77 CASR (0.47) AKT1ROCK2PIM1RPS6KB1GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293712-A1 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof WYETH (US) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293712-A1 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof PDPK1, PDK2, PDK3 AKT1 157/4885ROCK2 635/4885PIM1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.